Glassman Wealth Services Halozyme Therapeutics, Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$30.28 - $38.74 $242 - $309	-8 Reduced 10.53%	68 $2,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1,591 - $2,037	50 Added 192.31%	76 $3,000
Q1 2021 May 05, 2021	BUY	$39.51 - $51.45 $118 - $154	3 Added 13.04%	26 $1,000
Q2 2020 Aug 06, 2020	BUY	$16.25 - $26.81 $81 - $134	5 Added 27.78%	23 $1,000
Q4 2019 Feb 07, 2020	BUY	$14.93 - $19.53 $268 - $351	18 New	18 $0

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.